Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognosis Factors in Patients With Primary Central Nervous System Lymphoma

NCT05167630 is registered in ClinicalTrials.gov with Zhengzhou University as lead sponsor.

NCT NCT05167630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05167630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognosis Factors in Patients With Primary Central Nervous System Lymphoma
Lead sponsor
Zhengzhou University
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2013
Completion date
December 15, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcnsl, survival analysis